|
|
|
Insider
Information: |
Krop Julie |
Relationship: |
Chief Medical Officer |
City: |
Waltham |
State: |
MA |
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
1 |
|
Direct
Shares |
73,044 |
|
Indirect Shares
|
0 |
|
|
Direct
Value |
$1,004,355 |
|
|
Indirect Value
|
$0 |
|
|
Total
Shares |
73,044 |
|
|
Total
Value |
$1,004,355 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
0
|
0
|
Stock
price went up :
|
0
|
0
|
Stock
price went down : |
0
|
0
|
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
Percentage
Gain/Loss : |
0.0%
|
0.0%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
|
AMAG Pharmaceuticals Inc |
AMAG |
Chief Medical Officer |
2020-03-02 |
73,044 |
2015-06-01 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
20 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 1 of 1
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
AMAG |
AMAG Pharmaceuticals Inc |
SVP Clinical & Regulatory, CMO |
|
2015-06-01 |
4 |
A |
$0.00 |
$0 |
D/D |
22,000 |
22,000 |
0 |
- |
|
AMAG |
AMAG Pharmaceuticals Inc |
SVP Clinical & Regulatory, CMO |
|
2016-03-01 |
4 |
A |
$0.00 |
$0 |
D/D |
9,000 |
31,000 |
0 |
- |
|
AMAG |
AMAG Pharmaceuticals Inc |
SVP Clinical & Regulatory, CMO |
|
2016-06-01 |
4 |
D |
$22.13 |
$52,979 |
D/D |
(2,394) |
28,606 |
0 |
- |
|
AMAG |
AMAG Pharmaceuticals Inc |
SVP Clinical & Regulatory, CMO |
|
2016-10-20 |
4 |
AS |
$24.80 |
$122,462 |
D/D |
(4,938) |
23,668 |
0 |
- |
|
AMAG |
AMAG Pharmaceuticals Inc |
SVP Clinical & Regulatory, CMO |
|
2017-02-23 |
4 |
A |
$0.00 |
$0 |
D/D |
15,000 |
38,668 |
0 |
- |
|
AMAG |
AMAG Pharmaceuticals Inc |
SVP Clinical & Regulatory, CMO |
|
2017-03-01 |
4 |
D |
$22.85 |
$25,318 |
D/D |
(1,108) |
35,669 |
0 |
- |
|
AMAG |
AMAG Pharmaceuticals Inc |
SVP Clinical & Regulatory, CMO |
|
2017-05-01 |
4 |
AS |
$24.45 |
$46,235 |
D/D |
(1,891) |
36,777 |
0 |
- |
|
AMAG |
AMAG Pharmaceuticals Inc |
SVP Clinical & Regulatory, CMO |
|
2017-06-01 |
4 |
D |
$17.90 |
$42,871 |
D/D |
(2,395) |
33,274 |
0 |
- |
|
AMAG |
AMAG Pharmaceuticals Inc |
SVP Clinical & Regulatory, CMO |
|
2017-07-13 |
4 |
AS |
$20.00 |
$98,760 |
D/D |
(4,938) |
28,336 |
0 |
- |
|
AMAG |
AMAG Pharmaceuticals Inc |
EVP, CMO |
|
2018-03-02 |
4 |
D |
$21.00 |
$35,700 |
D/D |
(1,700) |
51,636 |
0 |
- |
|
AMAG |
AMAG Pharmaceuticals Inc |
EVP, CMO |
|
2018-03-02 |
4 |
A |
$0.00 |
$0 |
D/D |
25,000 |
53,336 |
0 |
- |
|
AMAG |
AMAG Pharmaceuticals Inc |
Chief Medical Officer |
|
2018-07-02 |
4 |
D |
$19.85 |
$42,896 |
D/D |
(2,161) |
49,475 |
0 |
- |
|
AMAG |
AMAG Pharmaceuticals Inc |
Chief Medical Officer |
|
2019-02-23 |
4 |
D |
$15.51 |
$13,478 |
D/D |
(869) |
48,606 |
0 |
- |
|
AMAG |
AMAG Pharmaceuticals Inc |
Chief Medical Officer |
|
2019-02-25 |
4 |
A |
$0.00 |
$0 |
D/D |
25,000 |
73,606 |
0 |
- |
|
AMAG |
AMAG Pharmaceuticals Inc |
Chief Medical Officer |
|
2019-03-01 |
4 |
D |
$14.76 |
$14,170 |
D/D |
(960) |
72,646 |
0 |
- |
|
AMAG |
AMAG Pharmaceuticals Inc |
Chief Medical Officer |
|
2019-03-02 |
4 |
D |
$14.76 |
$18,406 |
D/D |
(1,247) |
71,399 |
0 |
- |
|
AMAG |
AMAG Pharmaceuticals Inc |
Chief Medical Officer |
|
2019-05-28 |
4 |
B |
$9.91 |
$99,100 |
D/D |
10,000 |
81,399 |
2.74 |
- |
|
AMAG |
AMAG Pharmaceuticals Inc |
Chief Medical Officer |
|
2020-02-23 |
4 |
D |
$9.50 |
$8,237 |
D/D |
(867) |
83,032 |
0 |
- |
|
AMAG |
AMAG Pharmaceuticals Inc |
Chief Medical Officer |
|
2020-02-25 |
4 |
D |
$8.84 |
$10,210 |
D/D |
(1,155) |
81,877 |
0 |
- |
|
AMAG |
AMAG Pharmaceuticals Inc |
Chief Medical Officer |
|
2020-03-02 |
4 |
D |
$7.75 |
$10,331 |
D/D |
(1,333) |
73,044 |
0 |
- |
|
20 Records found
|
1
|
Page 1 of 1 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|